Antiphospholipid syndrome (APS) is an autoimmune disease characterised by the presence
of antiphospholipid antibodies (aPL). The antibodies currently included in the classification …

Pregnancy is a hemostatic challenge: women are prone to thromboembolism during their
pregnancy and at the same time, especially during delivery, there is substantial risk of …

Objective: This study was designed to evaluate the efficacy of aspirin or heparin or both in
the treatment for recurrent spontaneous abortion (RSA) in women with antiphospholipid …

Lupus anticoagulant (LA) has been associated with pregnancy complications and
pregnancy loss. Identification of predictive factors could aid in deciding on therapeutic …

Antiphospholipid syndrome (APS) is a rare systemic autoimmune disease, the obstetric
features of which include recurrent early miscarriage, fetal death at or beyond 10 weeks of …

Introduction: Important advancements in pregnancy outcome have been reported in women
with antiphospholipid antibodies (aPL), despite the fact that the treatment of aPL related …

Background There is a substantial body of research evaluating ways to prevent and manage
miscarriage, but all studies do not report on the same outcomes. Objective To review …

Clinical trials have shown that administering heparin during the luteal phase has beneficial
effects on implantation and live birth rates. Heparin exerts direct effects on decidual human …

Objective We aimed to evaluate the effect of different timing of initiation of low-molecular-
weight heparin (LMWH) administration on the pregnancy outcomes in women with …

Background: Previous clinical studies reported low molecular weight heparin (LMWH)
monotherpay has been utilized for the treatment of recurrent abortion (RCA) with …